Unichem Laboratories Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Attractively valued vs sector (P/E 31.7x vs industry 54.7x)
- Low debt relative to equity (D/E 0.2x)
Concerns
- Low capital efficiency (ROCE 4.1%)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,899 | ₹4.6L Cr | 36.1 | 5.46 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,100 | ₹2.4L Cr | 81.1 | 14.42 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,857 | ₹1.8L Cr | 82.8 | 19.58 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,650 | ₹1.2L Cr | 59.1 | 13.13 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,385 | ₹1.1L Cr | 31.3 | 3.25 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,120 | ₹1.1L Cr | 23 | 4.16 | 21.2 | 21.1 | 0.38 |
| LAURUSLABS Laurus Labs Limited | ₹1,840 | ₹99K Cr | 90.9 | 18.74 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
UNICHEMLAB · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% |
| FII | 0.84% | 0.90% | 0.89% | 0.94% | 1.05% | 0.98% |
| DII | 10.46% | 11.26% | 11.57% | 11.65% | 11.63% | 11.32% |
| Public | 18.47% | 17.63% | 17.32% | 17.17% | 17.11% | 17.47% |
Latest News
All newsUnichem Labs sees spurt in trading volume
*Unichem Labs sees spurt in trading volume*. The NSE has flagged a significant increase in trading volume for Unichem Laboratories Limited and sought clarification to safeguard investor interests. The company has submitted its response to the exchange. No fundamental trigger reported yet, but elevated activity warrants caution. 📊 *STOCKS:* UNICHEM | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #VolumeSpurt
Unichem Laboratories reports Q1 FY26 financial results
*Unichem Laboratories reports Q1 FY26 financial results*. Unichem Laboratories has announced its financial results for the quarter ended June 30, 2026. The filing marks the official release of key performance metrics for the first quarter. Traders will assess revenue, **profit margins**, and **YoY growth** to gauge performance. 📊 *STOCKS:* $UNICHEM | 🏢 *SECTOR:* Pharma | #HIGHIMPACT #Earnings
Unichem Labs sees spurt in trading volume
*Unichem Labs sees spurt in trading volume* Unichem Laboratories witnessed a significant spike in trading volume, prompting the NSE to seek clarification. The company has submitted its response to the exchange's query to ensure market transparency. Such volume surges often indicate new information or position buildup. 📊 *STOCKS:* UNICHEM | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #VolumeSpurt
Unichem Labs reports Q1 FY27 financial results
*Unichem Labs reports Q1 FY27 financial results* as published in newspapers on **August 12, 2026**, detailing performance for the quarter ended **June 30, 2026**. The filing confirms timely disclosure of financial results in line with regulatory norms. No immediate operational changes were indicated. 📊 *STOCKS:* $UNICHEM | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Earnings
Unichem Laboratories holds shareholder meeting on August 11, 2026
*Unichem Laboratories holds shareholder meeting on August 11, 2026*. The company submitted the scrutinizers' report and voting results to the stock exchange. The meeting details were disclosed as part of a routine corporate filing. No major decisions or announcements impacting trading were indicated. 📊 *STOCKS:* $UNICHEM | 🏢 *SECTOR:* Pharma | #LOWIMPACT #ShareholdersMeeting
Unichem Laboratories issues corporate update
*Unichem Laboratories issues corporate update* as per a recent NSE filing. The announcement does not disclose any financial or operational details. Traders should monitor for further clarifications. No immediate material impact expected. 📊 *STOCKS:* UNICHEM | 🏢 *SECTOR:* Pharma | #LOWIMPACT #corporateupdate
Unichem Labs announces e-voting for AGM
*Unichem Labs announces e-voting for AGM.* The company has released a newspaper publication detailing e-voting procedures for its **63rd Annual General Meeting**. Shareholders can participate electronically ahead of the event. No financial or strategic decisions were disclosed. 📊 *STOCKS:* UNICHEM | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AGM
Unichem Labs to hold shareholder meeting on August 11, 2026
*Unichem Labs to hold shareholder meeting on August 11, 2026.* The event is a routine corporate update with no **new financial disclosures** or strategic announcements. Shareholders will discuss **standard agenda items** as per regulatory norms. Impact on trading is expected to be minimal. 📊 *STOCKS:* UNICHEM | 🏢 *SECTOR:* Pharma | #LOWIMPACT #ShareholderMeeting
Unichem Labs releases BRSR report for FY26
Unichem Laboratories has filed its BRSR (Business Responsibility and Sustainability Report) for FY 2026. The report outlines the company’s ESG initiatives and sustainability practices. *Unichem Labs releases BRSR report for FY26*. This is a routine disclosure with no immediate financial impact. 📊 *STOCKS:* UNICHEM | 🏢 *SECTOR:* Pharma | #LOWIMPACT #ESG
Unichem Labs issues notice in newspapers as per MCA guidelines
*Unichem Labs issues notice in newspapers as per MCA guidelines.* The company published a notice on **16th June 2026** in accordance with Circular No. **20/2020** dated **5th May 2020** from the Ministry of Corporate Affairs. This is a routine compliance requirement and does not indicate operational changes. No financial impact is expected from this disclosure. 📊 *STOCKS:* UNICHEM | 🏢 *SECTOR:* Pharma | #LOWIMPACT #CorporateFiling